ALBENDAZOLE
Generic: ALBENDAZOLE
Amneal Pharmaceuticals of New York LLCManufacturer
ORALRoute
ALBENDAZOLEActive Substance
1996-06-11Original Approval
ALBENDAZOLE is FDA application NDA020666, sponsored by IMPAX LABS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
346 reports
2
OFF LABEL USE
276 reports
3
PYREXIA
218 reports
4
PRODUCT USE IN UNAPPROVED INDICATION
210 reports
5
HEADACHE
203 reports
6
CONDITION AGGRAVATED
200 reports
7
WEIGHT DECREASED
169 reports
8
PAIN
167 reports
9
RASH
164 reports
10
SOMNOLENCE
163 reports